BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 16879902)

  • 1. Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine.
    Schleiss MR; Stroup G; Pogorzelski K; McGregor A
    Vaccine; 2006 Sep; 24(37-39):6175-86. PubMed ID: 16879902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection.
    Schleiss MR; Bourne N; Bernstein DI
    J Infect Dis; 2003 Dec; 188(12):1868-74. PubMed ID: 14673766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality.
    Swanson EC; Gillis P; Hernandez-Alvarado N; Fernández-Alarcón C; Schmit M; Zabeli JC; Wussow F; Diamond DJ; Schleiss MR
    Vaccine; 2015 Jul; 33(32):4013-8. PubMed ID: 26079615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection.
    Bourne N; Schleiss MR; Bravo FJ; Bernstein DI
    J Infect Dis; 2001 Jan; 183(1):59-64. PubMed ID: 11087203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion of the Guinea Pig Cytomegalovirus Pentameric Complex in a Live Virus Vaccine Aids Efficacy against Congenital Infection but Is Not Essential for Improving Maternal and Neonatal Outcomes.
    Schleiss MR; Fernández-Alarcón C; Hernandez-Alvarado N; Wang JB; Geballe AP; McVoy MA
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection.
    Schleiss MR; Lacayo JC; Belkaid Y; McGregor A; Stroup G; Rayner J; Alterson K; Chulay JD; Smith JF
    J Infect Dis; 2007 Mar; 195(6):789-98. PubMed ID: 17299708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection.
    Cardin RD; Bravo FJ; Pullum DA; Orlinger K; Watson EM; Aspoeck A; Fuhrmann G; Guirakhoo F; Monath T; Bernstein DI
    Vaccine; 2016 Apr; 34(17):1993-9. PubMed ID: 26973071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine.
    Schleiss MR; Bourne N; Stroup G; Bravo FJ; Jensen NJ; Bernstein DI
    J Infect Dis; 2004 Apr; 189(8):1374-81. PubMed ID: 15073673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of maternal treatment with cyclic HPMPC in the guinea pig model of congenital cytomegalovirus infection.
    Bravo FJ; Cardin RD; Bernstein DI
    J Infect Dis; 2006 Feb; 193(4):591-7. PubMed ID: 16425139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with a Live Attenuated Cytomegalovirus Devoid of a Protein Kinase R Inhibitory Gene Results in Reduced Maternal Viremia and Improved Pregnancy Outcome in a Guinea Pig Congenital Infection Model.
    Schleiss MR; Bierle CJ; Swanson EC; McVoy MA; Wang JB; Al-Mahdi Z; Geballe AP
    J Virol; 2015 Oct; 89(19):9727-38. PubMed ID: 26178990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning of the guinea pig cytomegalovirus (GPCMV) genome as an infectious bacterial artificial chromosome (BAC) in Escherichia coli.
    McGregor A; Schleiss MR
    Mol Genet Metab; 2001 Jan; 72(1):15-26. PubMed ID: 11161824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models of congenital cytomegalovirus infection: an overview of progress in the characterization of guinea pig cytomegalovirus (GPCMV).
    Schleiss MR
    J Clin Virol; 2002 Aug; 25 Suppl 2():S37-49. PubMed ID: 12361755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic cidofovir (cHPMPC) prevents congenital cytomegalovirus infection in a guinea pig model.
    Schleiss MR; Anderson JL; McGregor A
    Virol J; 2006 Mar; 3():9. PubMed ID: 16509982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Non-Replication-Competent Cytomegalovirus Capsid Mutant Vaccine Strategy Is Effective in Reducing Congenital Infection.
    Choi KY; Root M; McGregor A
    J Virol; 2016 Sep; 90(17):7902-19. PubMed ID: 27334585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of vaccine strategies against congenital CMV infection in the guinea pig model.
    Schleiss MR
    J Clin Virol; 2008 Mar; 41(3):224-30. PubMed ID: 18060834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig model.
    Leviton MP; Lacayo JC; Choi KY; Hernandez-Alvarado N; Wey A; Schleiss MR
    Clin Dev Immunol; 2013; 2013():906948. PubMed ID: 24000289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of essential and non-essential genes of the guinea pig cytomegalovirus (GPCMV) genome via transposome mutagenesis of an infectious BAC clone.
    McGregor A; Liu F; Schleiss MR
    Virus Res; 2004 May; 101(2):101-8. PubMed ID: 15041177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model.
    Schleiss MR; Choi KY; Anderson J; Mash JG; Wettendorff M; Mossman S; Van Damme M
    Vaccine; 2014 May; 32(23):2756-62. PubMed ID: 23867012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against Congenital CMV Infection Conferred by MVA-Vectored Subunit Vaccines Extends to a Second Pregnancy after Maternal Challenge with a Heterologous, Novel Strain Variant.
    Fernández-Alarcón C; Buchholz G; Contreras H; Wussow F; Nguyen J; Diamond DJ; Schleiss MR
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced congenital cytomegalovirus (CMV) infection after maternal immunization with a guinea pig CMV glycoprotein before gestational primary CMV infection in the guinea pig model.
    Harrison CJ; Britt WJ; Chapman NM; Mullican J; Tracy S
    J Infect Dis; 1995 Nov; 172(5):1212-20. PubMed ID: 7594656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.